4th Quarter - Report

INTEGRATED SOLUTIONS GROUP for TEVA PHARMACEUTICALS USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitored legislation affecting medicaid and settlements

LobbyistCovered position, as disclosed
MOSES BOYD Counsel, Senate Commerce Committee
G JOHN O'HANLON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Copyright/Patent/Trademark CPT

S.23 America Invents Act, H.R. 1249 America Invents Act Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages

LobbyistCovered position, as disclosed
MOSES BOYD Counsel, Senate Commerce Committee
G JOHN O'HANLON —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.